Localized Ocular Adnexal Mucosa-Associated Lymphoid Tissue Lymphoma Treated With Radiation Therapy: A Long-Term Outcome in 86 Patients With 104 Treated Eyes
Ken Harada(Ibaraki University), Jun Itami(National Cancer Centre Japan), Shuhei Sekii(Tokyo National Hospital), Takashi Uno(Chiba University), Kotaro Yoshio(Okayama University Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Kensei Tobinai(National Cancer Center), Koji Inaba(National Cancer Center), Shigenobu Suzuki, Mayuka Kitaguchi(Tokyo National Hospital), Naoya Murakami(Tokushima University Hospital), Yoshinori Ito(Tokyo National Hospital), Madoka Morota(Japanese Foundation For Cancer Research), Kana Takahashi(Nihon University)
International Journal of Radiation Oncology*Biology*Physics
February 10, 2014
Cited by 67
Related Papers
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
|The Lancet|2018|733
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
|Blood|2011|431
Comprehensive Registry of Esophageal Cancer in Japan, 2009
|Esophagus|2016|258
Radiation pneumonitis in lung cancer patients: a retrospective study of risk factors and the long-term prognosis
|International Journal of Radiation Oncology*Biology*Physics|2001|188